JPRN-UMIN000004462
Completed
未知
The study for beneficial efficacy and safety of ezetimibe in patients with hyper LDL-cholesterolemia associated with diabetes mellitus (DM) including glucose intolerance and non-alcoholic fatty liver disease (NAFLD) - The study for beneficial efficacy of ezetimibe in patients with hyper LDL-cholesterolemia with diabetes and NAFLD
Geriatric Medicine, Osaka University Graduate School of Medicine0 sites20 target enrollmentNovember 1, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- non-alcoholic fatty liver disease, diabetes mellitus, hyper LDL-cholesterolemia
- Sponsor
- Geriatric Medicine, Osaka University Graduate School of Medicine
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) the subjects currently receiving ezetimibe 2\) the subjects infected with hepatitis B or C virus 3\) the subjects with more than 500mg/dl of triglyceride 4\) the subjects with familial hyperlipidemia, secondary hyperlipidemia and drug induced\-hyperlipidemia 5\) the subjects drinking alcohol more than 21g per day frequently 6\) the subjects receiving pioglitazone 7\) the subjects recommended the other medication 8\) the subjects with hyperlipidemia induced by: hypothyroidism, obstructive biliary tract disease, pancreatitis, cushing syndrome, lupus erythematosus, malignant lymphoma, myeloma. 9\) the subjects with poor controlled diabetes (HbA1c \> 9\.0%) 10\) the subjects having a history of a previous drug allergy 11\) the subjects during pregnancy or lactation 12\) the subjects found offensive by attending physicians for this research
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyEUCTR2004-003807-19-ESMerck & Co Inc.600
Active, not recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762EUCTR2004-003807-19-ATMerck, Sharp & Dohme600
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0 Level: LLT Classification code 10027762EUCTR2004-003807-19-GBMerck Sharp & Dohme Ltd600
Active, not recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762EUCTR2004-003807-19-HUMerck & Co., Inc.600
Not yet recruiting
Phase 2
Exploratory survey of the safety and efficacy of endoscopic radiofrequency ablation for malignant biliary strictureMalignant biliary strictureJPRN-UMIN000031601Graduate School of Medicine, Chiba University10